Core Scientific (CORZ) Q4 2025 Earnings Transcript
Trade with 70% Backtested Accuracy
Analyst Views on CORZ
About CORZ
About the author

- Bitcoin Holdings Reduction: As of Tuesday, Core Scientific holds fewer than 1,000 BTC and plans to sell the remainder in Q1 2026 to enhance liquidity and support its AI expansion efforts.
- Strong Financial Performance: The company reported a $175 million revenue from selling 1,900 BTC in Q4, demonstrating its active trading capabilities in the Bitcoin market.
- Liquidity Management Strategy: The CFO indicated that 2025 will be a transitional year, with plans to raise $4 billion in loans against contracts with CoreWeave to ensure funding for AI infrastructure investments.
- Power Capacity Expansion: Core Scientific has energized approximately 350 megawatts of capacity, with nearly 200 megawatts currently billing, indicating significant progress in expanding its colocation business.
- Core Scientific Needs: The article discusses the essential scientific requirements that need to be addressed for advancements in various fields.
- Raising Funds: It highlights the importance of raising funds to support these scientific endeavors and the potential impact on future research.
- Buying from Hold: The piece suggests a strategic shift in investment, recommending a move from a "hold" position to actively buying into promising scientific ventures.
- Future Implications: The discussion emphasizes the long-term benefits of investing in scientific research and its implications for innovation and technology.

Market Performance: Circle shares surged to a three-month high, while Core Scientific and Riot Platforms reported disappointing fourth-quarter results, falling short of Wall Street expectations.
Cryptocurrency Trends: Bitcoin prices climbed amid U.S.-Iran tensions, reaching around $70,000, with digital asset treasury firms announcing significant crypto purchases.
Retail Sentiment: Retail sentiment around Circle and Core Scientific stocks showed bullish trends, with increased chatter and improved sentiment levels, despite some caution regarding future price movements.
Earnings Reports: Core Scientific and Riot Platforms both reported losses that exceeded analyst expectations, leading to fluctuations in their stock prices and overall market sentiment in the cryptocurrency sector.
- Earnings Beat: Core Scientific reported a Q4 GAAP EPS of $0.42, exceeding expectations by $0.58, indicating strong profitability despite challenges in revenue generation.
- Revenue Decline: The company’s revenue of $79.8 million represents a 15.9% year-over-year decline, missing market expectations by $36.12 million, highlighting difficulties in maintaining growth in a competitive landscape.
- Data Center Expansion: Core Scientific plans to lease 400 MW of data center capacity to new clients in 2026, a strategic move aimed at addressing the increasing demand for AI computing and laying the groundwork for future revenue growth.
- Rating Upgrade: Following the termination of the CoreWeave deal, BTIG upgraded Core Scientific to a “Buy” rating, reflecting market confidence in the company’s future potential and likely attracting more investor interest.
- Diverging Software Performance: Major software companies like Salesforce, Intuit, and Adobe have seen stock prices drop over 50% from their all-time highs, reflecting the severe impact of AI disruption and diminishing investor confidence in the software sector.
- Strong Momentum Stocks: Despite the overall market downturn, companies like Teradata, Arteris, and Clear Secure have scored above 80 on Benzinga Edge's Momentum Score, indicating strong market momentum that could lead to greater gains if the sector rebounds.
- Arteris Price Breakout: The earnings report for Arteris caused its stock to break above the 50-day SMA for the first time since mid-January, accompanied by a bullish MACD crossover, suggesting a relatively strong performance in the software industry with potential for further upside.
- Mitek Systems Recovery: Mitek's positive earnings report has pushed its stock back above the 50-day SMA, with a year-to-date increase of over 35%, and if the fundamental and technical trends hold, MITK shares could see additional gains ahead.








